Tag: clinical study
Enrollment Complete for Phase 2b Probiotic Oral Immunotherapy Treatment Candidate
Study to provide evidence of longer lasting tolerance to peanut in a larger number of patients.
Study: Dupilumab Showed Positive Phase 3 Results in Adolescents with Inadequately...
"[dupilumab] blocks the IL-4/IL-13 pathway, which is emerging as a central driver of Type 2 allergic inflammation."
Study: IgG Antibodies Activate Blood Platelets and Contribute to the Severity...
"This work demonstrates the potential of exploring therapeutic interventions that target platelets as means of limiting the severity of anaphylactic shock."
Study: Pediatric Admissions Slashed With Simple Changes to Hospital Anaphylaxis Procedures
Researchers were able to streamline the care of patients with anaphylaxis without any compromise in safety.
Study: Immunotherapy Trials for Food Allergy Hold Strong Appeal for Parents
Child’s food allergies have major impact on parents’ lives; majority of parents are willing to enroll their child in an immunotherapy clinical trial
Aimmune to Submit FDA Application for Peanut OIT Candidate by End...
If approved, AR101 could be offered as the first FDA approved OIT therapy for peanut allergy.
Milk and Peanut Clinical Trial Advances
Announcements regarding two food allergy therapies that are in or advancing toward clinical trials were made yesterday.
Results of Phase III Trial of Aimmune’s Peanut OIT Therapy
After one year, 3/4 of patients ages 4-17 who received the therapy were able to consume a minimum of 300mg of peanut. Results for adults were less clear.
Study: Diagnosing Food Allergy via Fecal Sample
The study could lead to new diagnostics that may obviate the need for food challenges.
Aimmune Issues Update on AR101 Peanut Oral Immunotherapy Candidate
The company announces their timeline for continued progress toward an FDA approved standardized therapy.
